These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23517073)

  • 1. Obesity in Europe - does anybody care?
    Astrup A; Rössner S; Finer N; Van Gaal L
    Expert Opin Pharmacother; 2013 Jun; 14(8):971-3. PubMed ID: 23517073
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-obesity drugs: to be or not to be?
    Dvorak RV; Sharma AM; Astrup A
    Obes Rev; 2010 Dec; 11(12):833-4. PubMed ID: 21054758
    [No Abstract]   [Full Text] [Related]  

  • 3. Two new drugs approved for obesity.
    Johnson AM
    S D Med; 2012 Sep; 65(9):356-7. PubMed ID: 23066610
    [No Abstract]   [Full Text] [Related]  

  • 4. Companies throw their weight behind new antiobesity drugs.
    Cahoon L
    Nat Med; 2010 Feb; 16(2):136. PubMed ID: 20134442
    [No Abstract]   [Full Text] [Related]  

  • 5. Fat pill for teens. Xenical may have the FDA's blessing, but is it a good idea?
    Gupta S
    Time; 2003 Dec 29-2004 Jan 5; 162(26):162. PubMed ID: 14722944
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approves first canine diet drug.
    Nolen RS
    J Am Vet Med Assoc; 2007 Mar; 230(5):641-2. PubMed ID: 17380625
    [No Abstract]   [Full Text] [Related]  

  • 7. The fat of the matter.
    Nat Med; 2012 Aug; 18(8):1155. PubMed ID: 22869166
    [No Abstract]   [Full Text] [Related]  

  • 8. The FDA's assessment of two drugs for chronic weight management.
    Colman E; Golden J; Roberts M; Egan A; Weaver J; Rosebraugh C
    N Engl J Med; 2012 Oct; 367(17):1577-9. PubMed ID: 23050510
    [No Abstract]   [Full Text] [Related]  

  • 9. Are we treating health or physical appearance when we prescribe drugs for obesity?
    Reidenberg MM
    Clin Pharmacol Ther; 2000 Mar; 67(3):193-5. PubMed ID: 10741620
    [No Abstract]   [Full Text] [Related]  

  • 10. Orlistat half the dose without a prescription: new status. In excess body weight: often uncomfortable and don't expect miracles. Frequent gastrointestinal disturbances for a weight loss of a few kilos. Better to encourage dietary measures, exercise and individualised support.
    Prescrire Int; 2009 Jun; 18(101):101. PubMed ID: 19637413
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for approval of anti-obesity drugs affecting atherosclerosis and/or lipids. The international union of pharmacology (IUPHAR).
    Anderson JW
    Am J Cardiol; 1998 Apr; 81(8A):29F-30F. PubMed ID: 9604902
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a path for approval of an antiobesity drug: what did the Sibutramine Cardiovascular Outcomes Trial find?
    Downey M; Still C; Sharma AM
    Curr Opin Endocrinol Diabetes Obes; 2011 Oct; 18(5):321-7. PubMed ID: 21878755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight-loss drug for obese dogs.
    FDA Consum; 2007; 41(2):4. PubMed ID: 17582853
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide.
    Krentz AJ; Fujioka K; Hompesch M
    Drugs; 2015 Jun; 75(9):931-3. PubMed ID: 25963328
    [No Abstract]   [Full Text] [Related]  

  • 15. Employers, others not sold on new anti-obesity drugs.
    Reinke T
    Manag Care; 2012 Sep; 21(9):33-6. PubMed ID: 23050423
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approval of obesity drugs: a difference in risk-benefit perceptions.
    Morrato EH; Allison DB
    JAMA; 2012 Sep; 308(11):1097-8. PubMed ID: 22990266
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug treatment of obesity.
    Bray GA; Ryan DH
    Psychiatr Clin North Am; 2011 Dec; 34(4):871-80. PubMed ID: 22098810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development.
    Bays HE
    Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):265-77. PubMed ID: 21438803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slim spoils for obesity drugs.
    Ledford H
    Nature; 2010 Dec; 468(7326):878. PubMed ID: 21164452
    [No Abstract]   [Full Text] [Related]  

  • 20. European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes.
    Jordan J; Schlaich M; Redon J; Narkiewicz K; Luft FC; Grassi G; Dixon J; Lambert G; Engeli S; ;
    J Hypertens; 2011 Feb; 29(2):189-93. PubMed ID: 21178784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.